
Candid Therapeutics, Inc. has raised $206.2M in total funding.
Candid Therapeutics, Inc. is headquartered in San Diego, CA.
Founded by Ken Song and launched with over $370 million (later exceeding $500 million) from investors including Venrock Healthcare Capital Partners, RA Capital Management, and Fairmount.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.